Estonia has observed a 2.48 million (198.9%) increase in the research & development by business enterprise, pharmaceutical industry in current ppp $, which now stands at 3.73 million.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Estonia
No matching regions
Similar regions to Estonia
Business R&D pharmaceutical in current PPP $
More indicators for Estonia
Government R&D in security as % of government support
2.23%
-0.15%
(2021)
Higher-education-finacing R&D financed by general university in local currency
0.00M
0.00M
(2019)
R&D financed by rest of the world in local currency
579.01M
-16.79M
(2021)
Government R&D financed by rest of the world in local currency
53.01M
-19.99M
(2021)
Business R&D financed by rest of the world in local currency
187.84M
-34.36M
(2021)
Non-profit R&D growth rate
-45.86%
-26.71%
(2022)
Estonia Business R&D pharmaceutical in current PPP $ between 2010 and 2021
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2021 | 3.73M | +2.48M |
| 2019 | 1.25M | +0.13M |
| 2018 | 1.11M | -0.28M |
| 2017 | 1.39M | +0.60M |
| 2016 | 0.79M | -0.85M |
| 2015 | 1.64M | -0.50M |
| 2014 | 2.13M | +0.24M |
| 2013 | 1.89M | +0.16M |
| 2012 | 1.73M | -4.50M |
| 2011 | 6.23M | +5.77M |
| 2010 | 0.46M |